Veterinary Medicines

Bonharen IVN, 10mg/ml, Solution for injection

Authorised
  • SODIUM HYALURONATE
Download as PDF

Product identification

Medicine name:
Bonharen IVN, 10mg/ml, Solution for injection
BONHAREN IVN 10 mg/ml oldatos injekció lovak és kutyák számára A.U.V.
Active substance:
  • SODIUM HYALURONATE
Target species:
  • Horse
  • Dog
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • SODIUM HYALURONATE
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM09AX01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:
  • Glass Vial 5 x 6.0 millilitre(s)
  • Glass Vial 6 x 6.0 millilitre(s)
  • Glass Vial 3 x 6.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Contipro a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Contipro a.s.
Responsible authority:
  • National Food Chain Safety Office
Authorisation number:
  • 4113/X/19 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0163/001
Concerned member states:
  • Austria
  • Belgium
  • Hungary
  • Ireland
  • Slovakia
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."